Hospital-Acquired Infections: Acinetobacter radioresistens can cause hospital-acquired infections, especially in intensive care units (ICUs) and among patients with prolonged hospital stays. It can lead to various types of infections, including pneumonia, bloodstream infections (bacteremia), urinary tract infections, and wound infections.
Antibiotic Resistance: Acinetobacter radioresistens has demonstrated resistance to multiple antibiotics, including carbapenems and other broad-spectrum antibiotics. This can complicate the treatment of infections caused by this bacterium, leading to prolonged illness, treatment failure, and increased healthcare costs.
Nosocomial Outbreaks: Acinetobacter radioresistens has been implicated in nosocomial outbreaks in healthcare facilities, particularly when proper infection control measures are not followed. Contaminated medical devices, ventilators, and other equipment can serve as reservoirs for the bacterium, facilitating its transmission among patients.
Community-Acquired Infections: While less common, Acinetobacter radioresistens infections can also occur in community settings, particularly in individuals with underlying health conditions or those who have been exposed to healthcare environments.
Acinetobacter radioresistens impacts on other bacteria of the same rank
Other bacteria of the same rank impacting Acinetobacter radioresistens
This is an Academic site. It generates
theoretical models
of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some
hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]
